Filing Flows › Pacira BioSciences (PCRX) › Net product sales revenue
Pacira BioSciences (PCRX) Net product sales revenue by quarter
Pacira BioSciences' Net product sales revenue was $175M in Q3 2026 (third quarter 2026), -8% from Q2 2026. Over the last 5 quarters it ranged from $168M (Q1 2025) to $190M (Q2 2026).
| Quarter | Net product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $175M | -8% | -1% |
| Q2 2026 | $190M | +7% | +6% |
| Q3 2025 | $178M | -1% | — |
| Q2 2025 | $180M | +7% | — |
| Q1 2025 | $168M | — | — |
Q3 2026 at a glance
Pacira BioSciences, Q3 2026: revenue $177M (-2% year over year), operating margin 12.6%, net earnings $28.5M, operating cash flow $50.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pacira BioSciences' Net product sales revenue?
Pacira BioSciences' Net product sales revenue was $175M in Q3 2026 (third quarter 2026), -8% from Q2 2026.
How has Pacira BioSciences' Net product sales revenue changed?
Over the last 5 quarters it ranged from $168M (Q1 2025) to $190M (Q2 2026).